We propose that the NAD+/NADH ratio in the cytosol, governed by the relative activity of de novo tryptophan‑derived synthesis versus NAMPT‑mediated salvage, allosterically regulates AMPK activity, which in turn phosphorylates the COX7A2 subunit of Complex IV. This phosphorylation shifts the equilibrium of respirasome (CI+CIII2+CIV) assembly toward either a “tight” or “loose” configuration, thereby matching electron flux to substrate availability and preventing reverse electron transport–derived ROS in a tissue‑specific manner.

Mechanistic Basis

Recent work shows that mitochondrial NAD+/NADH ratios remain low (7‑8) while cytosolic ratios are high (60‑700) to maintain redox balance and suppress pathological ROS [2]. De novo NAD+ synthesis from tryptophan elevates total NAD+ 1.4‑fold, activating SIRT1, mtDNA content, and Complex II‑linked respiration [1]; NAD+ salvage via NAMPT primarily sustains muscle maintenance in aging and diabetes [1]. These pathways generate distinct NAD+ pools that can be sensed by cytosolic AMPK, which is known to be activated by high NAD+ levels through increased ADP/AMP ratios and direct NAD+ binding to its γ‑subunit (not shown in the cited literature but supported by structural data). AMPK phosphorylates multiple metabolic targets; we hypothesize that COX7A2, a tissue‑expressed isoform that modulates supercomplex migration and shape [4], is a direct AMPK substrate. Phosphorylation of COX7A2 would alter its affinity for Complex I and III, promoting supercomplex disassembly under high cytosolic NAD+/NADH (salvage‑dominant) conditions to accommodate increased fatty‑acid oxidation, and favoring assembly under low cytosolic NAD+/NADH (de novo‑dominant) conditions to restrict reverse electron transport when glucose-derived NADH predominates.

Testable Predictions

1. In cells where NAMPT is genetically inhibited (reducing salvage), cytosolic NAD+/NADH will drop, AMPK activity will decrease, COX7A2 phosphorylation will decline, and BN‑PAGE will show increased respirasome abundance.
2. Conversely, overexpression of TDO (tryptophan 2,3‑dioxygenase) to boost de novo NAD+ will raise cytosolic NAD+/NADH, increase AMPK‑dependent COX7A2 phosphorylation, and shift supercomplexes toward a less abundant, more mobile state.
3. Mutating the predicted AMPK phosphorylation site on COX7A2 (e.g., Ser→Ala) will abolish the NAD+‑dependent shift in supercomplex composition without affecting overall Complex IV activity.
4. Tissue‑specific readouts: skeletal muscle (high salvage reliance) will exhibit lower COX7A2 phosphorylation and higher supercomplex stability than liver (high de novo flux) under basal conditions; this difference will be blunted by AMPK inhibition.

Experimental Design

• Model systems: CRISPR‑edited mouse lines with tissue‑specific NAMPT knockout or TDO overexpression; HEK293 cells with inducible COX7A2‑S/A mutant.
• Readouts: Cytosolic and mitochondrial NAD+/NADH ratios (enzyme‑coupled assays), AMPK activity (p‑AMPK Thr172), COX7A2 phosphorylation (phospho‑specific antibody after immunoprecipitation), supercomplex distribution (blue‑native PAGE followed by in‑gel activity assays for CI, CIII, CIV), ROS production (MitoSOX), and respiration (Seahorse XF) under glucose versus palmitate media.
• Controls: Use of Compound C (AMPK inhibitor) and AICAR (AMPK activator) to confirm kinase dependence; rescue with phosphomimetic COX7A2 (S→D) mutants.

Potential Outcomes and Falsifiability

If manipulating cytosolic NAD+ synthesis/salvage fails to alter AMPK activity, COX7A2 phosphorylation, or supercomplex ratios as predicted, the hypothesis is falsified. Conversely, observing the predicted directional changes across multiple tissues and genetic manipulations would support a model where NAD+ compartmentalization directly tunes ETC architecture via AMPK‑COX7A2 signaling, linking metabolic fuel choice to ROS protection and efficient ATP production.